3T MRI capabilities provide high-quality images of the prostate gland and decrease scan times without the use of an endorectal coil to maximize patient comfort.
Delayed T1 Fat Supression is used to improve depictions of lesions by differentiating between tissues of interest.
Diffusion weighted imaging (DWI) with ADC mapping has shown to improve cancer detection rates and assessments for treatment responses.
PYLARIFY® Pifluotflastat F18 Injection combines the accuracy of PET/CT imaging and the clarity of an F18 radioisotope to reduce the risk of under or over treatment in individuals.
3D DynaCad Digital Imaging System provides advanced 3D models of lesions and the prostate gland to support image-guided biopsies.
Prostate Imaging Reporting Data System (PI-RADS) accelerates the transfer of high quality MRI results from research laboratories to patients.
We will connect you with a representative to answer any questions you may have so you can get your patients the imaging they need.
"*" indicates required fields